Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma

BACKGROUND: Oral squamous cell carcinoma (OSCC) constitutes 3 percent of all cancers with predominant occurrence in middle aged and elderly males. Tumour recurrence worsens disease prognosis and decreases quality of life in patients with OSCC. Proinflammatory cytokines such as interleukin-6 (IL-6) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrinjar, Ivana, Brailo, Vlaho, Vidovic-Juras, Danica, Vucicevic-Boras, Vanja, Milenovic, Aleksandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523251/
https://www.ncbi.nlm.nih.gov/pubmed/25858079
http://dx.doi.org/10.4317/medoral.20373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523251/
https://www.ncbi.nlm.nih.gov/pubmed/25858079
http://dx.doi.org/10.4317/medoral.20373

Ejemplares similares